Craig A. Wheeler

2017

In 2017, Craig A. Wheeler earned a total compensation of $4.8M as President, Chief Executive Officer and Director at Momenta Pharmaceuticals, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$480,000
Option Awards$1,776,463
Salary$750,000
Stock Awards$1,743,625
Other$34,551
Total$4,784,639

Wheeler received $1.8M in option awards, accounting for 37% of the total pay in 2017.

Wheeler also received $480K in non-equity incentive plan, $750K in salary, $1.7M in stock awards and $34.6K in other compensation.

Rankings

In 2017, Craig A. Wheeler's compensation ranked 2,015th out of 14,666 executives tracked by ExecPay. In other words, Wheeler earned more than 86.3% of executives.

ClassificationRankingPercentile
All
2,015
out of 14,666
86th
Division
Manufacturing
685
out of 5,772
88th
Major group
Chemicals And Allied Products
183
out of 2,075
91st
Industry group
Drugs
136
out of 1,731
92nd
Industry
Biological Products, Except Diagnostic Substances
30
out of 313
90th
Source: SEC filing on April 27, 2018.

Wheeler's colleagues

We found five more compensation records of executives who worked with Craig A. Wheeler at Momenta Pharmaceuticals in 2017.

2017

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2017

Matthew Ottmer

Momenta Pharmaceuticals

Chief Operating Officer

2017

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Operating Officer

2017

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2017

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

News

You may also like